Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
O-I Glass Reports Third Quarter 2025 Results
-
Par Pacific Holdings Reports Third Quarter 2025 Results
-
Great Elm Capital Corp. Announces Third Quarter 2025 Financial Results
-
Fuel Tech Reports 2025 Third Quarter Financial Results
-
HP Inc. to Announce Fourth Quarter Fiscal 2025 Earnings on Nov 25, 2025
-
Highwoods Prices $350 Million of 5.350% Notes Due 2033
-
CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2025
-
AMD Reports Third Quarter 2025 Financial Results
-
Navigator Gas Announces Preliminary Third Quarter 2025 Results (Unaudited)
-
Anaptys Announces Third Quarter 2025 Financial Results and Provides Business Update
-
Anaptys Announces Participation in November Investor Conferences
-
Bakkt Completes Capital Structure Simplification and Single-Class Stock Transition
-
Whitestone REIT Receives Unsolicited, Non-Binding Acquisition Proposal
-
Macerich Reports Third Quarter 2025 Earnings Results
-
Business Strategy Update – the “Forward” Strategic Direction, Aspirations towards 2028 and Funding Needs
-
Empathia Launches Crisis Leadership Program to Help Organizations Navigate Uncertainty in Today’s Challenging World
-
Applied Optoelectronics Announces Equity Grants To Employees Under Inducement Plan
-
Angi Inc. Earnings Release and Letter to Shareholders Available on Company’s Website
-
Pre-announcement of the Key Financial Results for Third Quarter 2025 and Revised Guidance for 2025
-
Progress Update on BioPorto’s Adult Clinical Study
-
Synchronoss Technologies Reports Third Quarter 2025 Results
-
LifeVantage Declares Quarterly Dividend
-
Sight Sciences to Present at Two Upcoming Investor Conferences
-
Clover Health Reports Third Quarter 2025 Results
-
Spero Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 13, 2025
-
LifeVantage Announces Financial Results for the First Quarter of Fiscal 2026
-
Arteris Announces Financial Results for the Third Quarter and Estimated Fourth Quarter and Updated Full Year 2025 Guidance
-
Standard BioTools Reports Third Quarter 2025 Financial Results
-
Weyco Reports Third Quarter 2025 Sales and Earnings; Declares Special Cash Dividend of $2.00 per Share
-
Pool Corporation Announces Upcoming Investor Conference Participation
-
Protara Therapeutics Named a 2026 Best Places to Work Winner by BioSpace
-
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Revolution Medicines to Participate in November 2025 Investor Conferences
-
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
-
DMC Global Reports Third Quarter Financial Results
-
Longeveron® Announces Third Quarter 2025 Financial Results and Provides Business Update
-
ImmuCell Announces Onboarding of New CEO and Related Management Changes
-
Arteris Selected by Altera to Advance Intelligent Computing Across Cloud-to-Edge Applications
-
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
-
Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit
-
OnKure Therapeutics to Participate in Upcoming Investor Conferences
-
Oportun Delivers Fourth Consecutive Quarter of GAAP Profitability, Increases Full-Year 2025 Adjusted EPS Guidance
-
Postal Realty Trust, Inc. Reports Third Quarter 2025 Results
-
The Tile Shop Reports Third Quarter 2025 Results
-
SuRo Capital Corp. Reports Third Quarter 2025 Financial Results
-
Ultragenyx Reports Third Quarter 2025 Financial Results and Corporate Update
-
Inspirato Reports Q3 Financial and Operating Results
-
Solana Company Files Application to Cease to Be a Reporting Issuer in Canada
-
Carlyle Secured Lending, Inc. Announces Financial Results For Third Quarter Ended September 30, 2025, Declares Fourth Quarter 2025 Dividend of $0.40 Per Common Share
-
Biomea Fusion Reports Third Quarter 2025 Financial Results and Corporate Highlights

